TABLE OF CONTENTS
1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 OVERVIEW OF GLOBAL ECLINICAL SOLUTIONS MARKET 21
1.4 LIMITATIONS 22
1.5 MARKETS COVERED 23
2 MARKET SEGMENTATION 25
2.1 MARKETS COVERED 25
2.2 GLOBAL ECLINICAL SOLUTIONS MARKET: GEOGRAPHICAL SCOPE 26
2.3 YEARS CONSIDERED FOR THE STUDY 27
2.4 CURRENCY AND PRICING 27
2.5 DBMR TRIPOD DATA VALIDATION MODEL 28
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 31
2.7 DBMR MARKET POSITION GRID 32
2.8 MULTIVARIATE MODELING 33
2.9 PRODUCTS LIFELINE CURVE 33
2.10 SECONDARY SOURCES 34
2.11 ASSUMPTIONS 34
3 MARKET OVERVIEW 35
3.1 DRIVERS 37
3.1.1 INCREASING ADOPTION OF CLINICAL TRIALS 37
3.1.2 RISING GOVERNMENT INITIATIVES 39
3.1.3 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATION 40
3.1.4 INCREASE IN R & D EXPENDITURE BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 41
3.2 RESTRAINTS 44
3.2.1 DEARTH OF TRAINED PROFESSIONALS 44
3.2.2 HIGH IMPLEMENTATION COST 45
3.3 OPPORTUNITIES 46
3.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 46
3.3.2 TECHNOLOGICAL ADVANCEMENT 47
3.4 CHALLENGES 48
3.4.1 STRINGENT REGULATIONS 48
4 EXECUTIVE SUMMARY 49
5 PREMIUM INSIGHTS 51
6 GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT 53
6.1 OVERVIEW 54
6.2 ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS) 55
6.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) 56
6.4 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) 56
6.5 ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) 57
6.6 ELECTRONIC TRIAL MASTER FILE SYSTEM 57
6.7 SAFETY SOLUTIONS 58
6.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS 58
6.9 CLINICAL DATA INTEGRATION PLATFORMS 59
6.10 CLINICAL ANALYTICS PLATFORMS 59
6.11 OTHER ECLINICAL SOLUTIONS 60
7 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE 61
7.1 OVERVIEW 62
7.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS 63
7.3 CLOUD-BASED (SAAS) SOLUTIONS 63
7.4 LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS 64
8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE 65
8.1 OVERVIEW 66
8.2 PHASE III 67
8.3 PHASE II 67
8.4 PHASE IV 68
8.5 PHASE I 68
9 GLOBAL ECLINICAL SOLUTIONSMARKET, BY END USER 69
9.1 OVERVIEW 70
9.2 HOSPITALS/HEALTHCARE PROVIDERS 71
9.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) 72
9.4 ACADEMIC INSTITUTES 72
9.5 PHARMA & BIOTECH ORGANIZATIONS 73
9.6 MEDICAL DEVICE MANUFACTURERS 73
9.7 CONSULTING SERVICE COMPANIES 74
?
10 GLOBAL ECLINICAL SOLUTIONS MARKET, BY GEOGRAPHY 75
10.1 OVERVIEW 76
10.2 NORTH AMERICA 81
10.2.1 U.S. 86
10.2.2 CANADA 88
10.2.3 MEXICO 90
10.3 EUROPE 92
10.3.1 GERMANY 97
10.3.2 U.K. 99
10.3.3 ITALY 101
10.3.4 FRANCE 103
10.3.5 RUSSIA 105
10.3.6 SWITZERLAND 107
10.3.7 NETHERLANDS 109
10.3.8 SPAIN 111
10.3.9 TURKEY 113
10.3.10 BELGIUM 115
10.3.11 REST OF EUROPE 117
10.4 ASIA-PACIFIC 118
10.4.1 JAPAN 123
10.4.2 CHINA 125
10.4.3 INDIA 127
10.4.4 SOUTH KOREA 129
10.4.5 AUSTRALIA 131
10.4.6 SINGAPORE 133
10.4.7 THAILAND 135
10.4.8 MALAYSIA 137
10.4.9 INDONESIA 139
10.4.10 PHILIPPINES 141
10.4.11 REST OF ASIA-PACIFIC 143
10.5 SOUTH AMERICA 144
10.5.1 BRAZIL 149
10.5.2 REST OF SOUTH AMERICA 151
10.6 MIDDLE EAST AND AFRICA 152
10.6.1 SOUTH AFRICA 157
10.6.2 REST OF MIDDLE EAST AND AFRICA 159
?
11 GLOBAL ECLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE 160
11.1 COMPANY SHARE ANALYSIS: GLOBAL 160
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 161
11.3 COMPANY SHARE ANALYSIS: EUROPE 162
11.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC 163
12 COMPANY PROFILE 164
12.1 ORACLE 164
12.1.1 COMPANY SNAPSHOT 164
12.1.2 REVENUE ANALYSIS 164
12.1.3 COMPANY SHARE ANALYSIS 165
12.1.4 PRODUCT PORTFOLIO 165
12.1.5 RECENT DEVELOPMENTS 165
12.2 MEDIDATA SOLUTIONS 166
12.2.1 COMPANY SNAPSHOT 166
12.2.2 REVENUE ANALYSIS 166
12.2.3 COMPANY SHARE ANALYSIS 167
12.2.4 PRODUCT PORTFOLIO 167
12.2.5 RECENT DEVELOPMENT 167
12.3 PAREXEL INTERNATIONAL CORPORATION 168
12.3.1 COMPANY SNAPSHOT 168
12.3.2 COMPANY SHARE ANALYSIS 168
12.3.3 PRODUCT PORTFOLIO 169
12.3.4 RECENT DEVELOPMENTS 169
12.4 BIOCLINICA 170
12.4.1 COMPANY SNAPSHOT 170
12.4.2 PRODUCT PORTFOLIO 170
12.4.3 RECENT DEVELOPMENTS 171
12.5 ERT CLINICAL 172
12.5.1 COMPANY SNAPSHOT 172
12.5.2 PRODUCT PORTFOLIO 172
12.5.3 RECENT DEVELOPMENTS 172
12.6 ARIS GLOBAL 173
12.6.1 COMPANY SNAPSHOT 173
12.6.2 PRODUCT PORTFOLIO 173
12.6.3 RECENT DEVELOPMENTS 174
12.7 ADVARRA 175
12.7.1 COMPANY SNAPSHOT 175
12.7.2 PRODUCT PORTFOLIO 175
12.7.3 RECENT DEVELOPMENTS 176
12.8 ANJU SOFTWARE 177
12.8.1 COMPANY SNAPSHOT 177
12.8.2 PRODUCT PORTFOLIO 177
12.8.3 RECENT DEVELOPMENTS 177
12.9 BIO-OPTRONICS, INC 178
12.9.1 COMPANY SNAPSHOT 178
12.9.2 PRODUCT PORTFOLIO 178
12.9.3 RECENT DEVELOPMENTS 178
12.10 DATATRAK INT. 180
12.10.1 COMPANY SNAPSHOT 180
12.10.2 REVENUE ANALYSIS 180
12.10.3 SOLUTION PORTFOLIO 181
12.10.4 RECENT DEVELOPMENTS 181
12.11 ECLINICALWORKS 182
12.11.1 COMPANY SNAPSHOT 182
12.11.2 PRODUCT PORTFOLIO 182
12.11.3 RECENT DEVELOPMENTS 182
12.12 ECLINICAL SOLUTIONS LLC 183
12.12.1 COMPANY SNAPSHOT 183
12.12.2 PRODUCT PORTFOLIO 183
12.12.3 RECENT DEVELOPMENTS 183
12.13 IBM CORPORATION 184
12.13.1 COMPANY SNAPSHOT 184
12.13.2 REVENUE ANALYSIS 184
12.13.3 PRODUCT PORTFOLIO 185
12.13.4 RECENT DEVELOPMENT 185
12.14 ICON PLC 186
12.14.1 COMPANY SNAPSHOT 186
12.14.2 REVENUE ANALYSIS 186
12.14.3 SERVICE PORTFOLIO 186
12.14.4 RECENT DEVELOPMENTS 187
12.15 MASTERCONTROL, INC. 188
12.15.1 COMPANY SNAPSHOT 188
12.15.2 SOLUTION PORTFOLIO 188
12.15.3 RECENT DEVELOPMENTS 188
12.16 MAXISIT 189
12.16.1 COMPANY SNAPSHOT 189
12.16.2 PRODUCT PORTFOLIO 189
12.16.3 RECENT DEVELOPMENT 189
?
12.17 OMNICOMM SYSTEMS, INC 190
12.17.1 COMPANY SNAPSHOT 190
12.17.2 REVENUE ANALYSIS 190
12.17.3 PRODUCT PORTFOLIO 191
12.17.4 RECENT DEVELOPMENTS 191
12.18 RESONANCE HEALTH 192
12.18.1 COMPANY SNAPSHOT 192
12.18.2 REVENUE ANALYSIS 192
12.18.3 PRODUCT PORTFOLIO 193
12.18.4 RECENT DEVELOPMENTS 193
12.19 REALTIME 194
12.19.1 COMPANY SNAPSHOT 194
12.19.2 PRODUCT PORTFOLIO 194
12.19.3 RECENT DEVELOPMENT 194
12.20 SIGNANT HEALTH 195
12.20.1 COMPANY SNAPSHOT 195
12.20.2 SOLUTION PORTFOLIO 195
12.20.3 RECENT DEVELOPMENTS 195
12.21 VEEVA SYSTEMS 196
12.21.1 COMPANY SNAPSHOT 196
12.21.2 REVENUE ANALYSIS 196
12.21.3 COMPANY SHARE ANALYSIS 197
12.21.4 PRODUCT PORTFOLIO 197
12.21.5 RECENT DEVELOPMENT 197
12.22 XYBION CORPORATION 198
12.22.1 COMPANY SNAPSHOT 198
12.22.2 PRODUCT PORTFOLIO 198
12.22.3 RECENT DEVELOPMENTS 199
13 QUESTIONNAIRE 200
14 RELATED REPORTS 203